Todd C. Brady
2022
In 2022, Todd C. Brady earned a total compensation of $2.9M as President and Chief Executive Officer at Aldeyra Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $338,410 |
---|---|
Option Awards | $818,523 |
Salary | $559,357 |
Stock Awards | $1,130,000 |
Other | $12,200 |
Total | $2,858,490 |
Brady received $1.1M in stock awards, accounting for 40% of the total pay in 2022.
Brady also received $338.4K in non-equity incentive plan, $818.5K in option awards, $559.4K in salary and $12.2K in other compensation.
Rankings
In 2022, Todd C. Brady's compensation ranked 1,273rd out of 5,753 executives tracked by ExecPay. In other words, Brady earned more than 77.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,273 | 78th |
Manufacturing | 627 | 80th |
Chemicals And Allied Products | 232 | 84th |
Drugs | 211 | 84th |
Pharmaceutical Preparations | 152 | 84th |
Brady's colleagues
We found two more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2022.
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019